Behrad Derakhshan - 01 May 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Chief Business Officer
Signature: /s/ John R Moore Attorney-in-Fact for Behrad Derakhshan
Issuer symbol: EWTX
Transactions as of: 01 May 2025
Net transactions value: -$27,824
Form type: 4
Filing time: 07 May 2025, 21:09:15 UTC
Previous filing: 07 Feb 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Derakhshan Behrad	Chief Business Officer	C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER	/s/ John R Moore Attorney-in-Fact for Behrad Derakhshan	07 May 2025	0001853109

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Options Exercise	$0	+5,209	+31%	$0.000000	22,046	01 May 2025	Direct
transaction	EWTX	Common Stock	Sale	$27,824	-1,691	-7.7%	$16.45	20,355	02 May 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Restricted Stock Units	Options Exercise	$0	-5,209	-100%	$0.000000	0	01 May 2025	Common Stock	5,209	$0.000000	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
F2	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.